| Literature DB >> 26626461 |
Marta Szabat1, Melissa M Page1, Evgeniy Panzhinskiy1, Søs Skovsø1, Majid Mojibian1, Juan Fernandez-Tajes2, Jennifer E Bruin1, Michael J Bround1, Jason T C Lee1, Eric E Xu3, Farnaz Taghizadeh1, Shannon O'Dwyer1, Martijn van de Bunt2, Kyung-Mee Moon4, Sunita Sinha5, Jun Han6, Yong Fan7, Francis C Lynn3, Massimo Trucco7, Christoph H Borchers6, Leonard J Foster4, Corey Nislow5, Timothy J Kieffer1, James D Johnson8.
Abstract
Pancreatic β cells are mostly post-mitotic, but it is unclear what locks them in this state. Perturbations including uncontrolled hyperglycemia can drive β cells into more pliable states with reduced cellular insulin levels, increased β cell proliferation, and hormone mis-expression, but it is unknown whether reduced insulin production itself plays a role. Here, we define the effects of ∼50% reduced insulin production in Ins1(-/-):Ins2(f/f):Pdx1Cre(ERT):mTmG mice prior to robust hyperglycemia. Transcriptome, proteome, and network analysis revealed alleviation of chronic endoplasmic reticulum (ER) stress, indicated by reduced Ddit3, Trib3, and Atf4 expression; reduced Xbp1 splicing; and reduced phospho-eIF2α. This state was associated with hyper-phosphorylation of Akt, which is negatively regulated by Trib3, and with cyclinD1 upregulation. Remarkably, β cell proliferation was increased 2-fold after reduced insulin production independently of hyperglycemia. Eventually, recombined cells mis-expressed glucagon in the hyperglycemic state. We conclude that the normally high rate of insulin production suppresses β cell proliferation in a cell-autonomous manner.Entities:
Keywords: ER stress; beta cells; dedifferentiation; diabetes; insulin; islets; metabolomic; proliferation; protein synthesis; proteomic; transcriptomic
Mesh:
Substances:
Year: 2015 PMID: 26626461 DOI: 10.1016/j.cmet.2015.10.016
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287